A Qualitative Study on Advanced Breast Cancer Patients and Their Caregivers in Spain

Gilead Sciences

Status: Completed

Conditions: Breast Cancer

Treatments: Other: No intervention

Study type: Observational

Funder types: Industry

Identifiers

NCT06683482

GS-ES-984-6674

Details and patient eligibility

About

The main goal of this ethnographic study is to learn a holistic and enriched view of the behaviors, actions, and views of a group of people with advanced breast cancer (ABC) cancer living in Spain. The primary objective of this study is to collect data on the psychosocial needs of (ABC) patients to identify spaces and strategies to improve these needs.

Enrollment: 41 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Key Inclusion Criteria:

1. Informed consent to individual in the qualitative study and to allow the recording of the interview for analyses purposes (individual and/or caregiver).
2. Women or men (individual and/or caregiver) over 18 years of age.
3. Confirmed diagnosis of triple-negative breast cancer (TNBC), hormone receptor (HR)+/ human epidermal growth factor receptor 2 (HER2)-, HER2+ unresectable locally advanced breast cancer (ULABC) or metastatic breast cancer (mBC) (individual).
4. Individuals must have initiated at least the firstline treatment.
5. Functional status according to the Eastern Cooperative Oncology Group (ECOG) scale 0-2 (individual).
6. Ability to conduct interviews from home (individual and/or caregiver) or remotely (ie, with technology available for an online interview).

Key Exclusion Criteria:

1. Individual unable to collaborate in the collection of necessary information (alteration in mental status, noncollaboration, limited language comprehension).
2. Individual unable or unwilling to provide informed consent.

Note: Other protocol defined Inclusion/Exclusion criteria may apply

Trial design

41 participants in 1 patient group

Participants with Advanced Breast Cancer Living in Spain and their Caregivers

Description:

Participants with different types of breast cancers living in Spain will be observed in this study. Participants will not receive any study drug in this study.

Treatment:

Other: No intervention